Answers are grounded in this paper and cite their sources.
Aerosolized delivery of virulent or hypervirulent Mycobacterium tuberculosis requires careful consideration of methodology and safety. To maximize safety, we installed a nose-only aerosol apparatus that can reproducibly deliver a low dose (<100 CFU per mouse) of M. tuberculosis in a carefully designed biohazard facility.
No takes yet. Share an insight, caveat, or question.
Schwebach et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: